Hantavirus cases spark surge in pharma and biotech stocks — here’s why
RSS SUMMARY · AGGREGATED FROM CNBC
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
Business
April home sales disappoint as higher mortgage rates weigh on buyers
CNBC·7m ago·3 min read
US
‘The haters will hate’: Dan Ives predicts Nasdaq 30,000 as AI rally expands
CNBC·1h ago·3 min read
Business
High gas prices are hurting restaurant sales — but not all chains
CNBC·1h ago·3 min read
Business
At TV upfronts, AI is in and corporate shuffles are reshaping the line-up
CNBC·1h ago·3 min read
Related
On this beat
Health
Health Care Roundup: Market Talk
TWSJ·2h ago·3 min read
Health
Beyond The Glass Skin: Why Smile Longevity Is Singapore’s Newest Beauty Standard
AOHL·2h ago·3 min read
Health
Are Microplastics In Your Drinking Water? Here Is What You Need To Know
AOHL·2h ago·3 min read
Health
A Single Infusion Could Suppress H.I.V. for Years, Study Suggests
TNYT·4h ago·3 min read